Insider · CIK 0001245607
Irit Arbel
Files at BCLI (BRAINSTORM CELL THERAPEUTICS INC.). First filing -, latest -.
In brief
Irit Arbel files SEC Form 4 as director at BCLI (BRAINSTORM CELL THERAPEUTICS INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Irit Arbel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | AGrant or award Common Stock | +120,000 | $0.00 | $0 | 161,054 | May 29, 2026 |
| Jan 1, 2025 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | AGrant or award Common Stock | +30,666 | $0.00 | $0 | 41,054 | Jan 3, 2025 |
Questions about Irit Arbel
Answered from the filings on this page, as of the latest one.
Is Irit Arbel buying or selling?
Irit Arbel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Irit Arbel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Irit Arbel has 0.
Where does Irit Arbel file Form 4?
Irit Arbel has filed Form 4 at BCLI (BRAINSTORM CELL THERAPEUTICS INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.